30th Sep 2016 15:16
30 September 2016
Byotrol plc
("Byotrol" or the "Company")
Result of Noteholders meeting
Further to the announcement on 9 September 2016, the Company is pleased to announce that at the Noteholders' meeting, held earlier today, the resolution to amend certain terms of the Loan Notes issued to the Noteholders on 20 December 2013 was duly approved.
Specifically, it was proposed that the Noteholders agree to rollover the maturity of the Loan Notes, which was originally set at three years, being the 20 December 2016. Pursuant to the meeting today, it has been agreed that the Loan Notes be extended by a further two years, resulting in a total term of the Loan Notes of five years. All other terms remain the same.
Enquiries:
Byotrol plc | 01925 742 000 |
David Traynor - Chief Executive
| |
finnCap Ltd | 020 7220 0500 |
(Nominated Adviser & Broker) | |
Geoff Nash/Carl Holmes/James Thompson - Corporate Finance | |
Mia Gardner - Corporate Broking | |
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial technologies.Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens
Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.
For more information, please go to www.byotrol.co.uk
Related Shares:
BYOT.L